# FDA 483 - Hendrick Regional Blood Center - March 07, 2022

Source: https://www.globalkeysolutions.net/records/483/hendrick-regional-blood-center/8e729da1-166e-49bf-9c8a-f19e62d490bd

> FDA 483 for Hendrick Regional Blood Center on March 07, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hendrick Regional Blood Center
- Inspection Date: 2022-03-07
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Hendrick Regional Blood Center in Abilene, TX, revealed multiple significant deficiencies in donor screening and blood collection processes. The firm failed to adequately inspect donors for signs of intravenous drug use, adhere to standard operating procedures for severe donor reactions and deferrals, and ensure proper donor weighing and privacy during screening. These observations indicate a concerning lack of compliance with federal regulations governing blood bank operations.

## Related Officers

- [Emily S. McGann](https://www.globalkeysolutions.net/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [Gloria A. Milster](https://www.globalkeysolutions.net/people/gloria-a-milster/22f95276-6f68-467d-8d52-5c028c118123)

Company: https://www.globalkeysolutions.net/companies/hendrick-regional-blood-center/45e2bd4e-ea3c-465a-9290-e488eb322e6f

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab